| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 382 |
| 1 | PREDNISONE | 122 |
| 2 | METHOTREXATE SODIUM | 118 |
| 3 | VEDOLIZUMAB | 117 |
| 4 | INFLIXIMAB | 108 |
| 5 | AZATHIOPRINE | 105 |
| 6 | METHOTREXATE | 96 |
| 7 | PANTOPRAZOLE | 94 |
| 8 | PREDNISOLONE | 87 |
| 9 | PREDNISOLONE ORAL | 87 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLAVOXATE HYDROCHLORIDE | 1 | 0.0099 |
| 1 | 3% SODIUM CHLORIDE | 1 | 0.0088 |
| 2 | INFLIXIMAB-DYYB | 28 | 0.0081 |
| 3 | SODIUM SULFACETAMIDE | 1 | 0.0055 |
| 4 | SACCHAROMYCES CEREVISIAE | 5 | 0.0054 |
| 5 | CETYLPYRIDINIUM CHLORIDE | 2 | 0.0031 |
| 6 | SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID | 2 | 0.0028 |
| 7 | TRIMIPRAMINE | 3 | 0.0027 |
| 8 | METEX | 1 | 0.0026 |
| 9 | PURIXAN | 2 | 0.0026 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 326 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 169 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 164 |
| 3 | Integrin Receptor Antagonist [EPC] | 124 |
| 4 | Interleukin-23 Antagonist [EPC] | 121 |
| 5 | Purine Antimetabolite [EPC] | 114 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 102 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 100 |
| 8 | Proton Pump Inhibitor [EPC] | 88 |
| 9 | Janus Kinase Inhibitor [EPC] | 81 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 21 | 0.0305 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 7 | 0.0034 |
| 2 | Serotonin-4 Receptor Agonist [EPC] | 2 | 0.0030 |
| 3 | Non-Standardized Fungal Allergenic Extract [EPC] | 5 | 0.0023 |
| 4 | Provitamin D2 Compound [EPC] | 69 | 0.0023 |
| 5 | Bile Acid Sequestrant [EPC] | 26 | 0.0021 |
| 6 | Asparagine-specific Enzyme [EPC] | 25 | 0.0019 |
| 7 | Integrin Receptor Antagonist [EPC] | 124 | 0.0014 |
| 8 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 9 | Interleukin-23 Antagonist [EPC] | 121 | 0.0012 |